サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：迅速微生物検査市場 - 成長、将来展望、競合分析、2025年～2033年
市場調査レポート
商品コード
1665899

迅速微生物検査市場 - 成長、将来展望、競合分析、2025年～2033年

Rapid Microbiology Tests Market - Growth, Future Prospects and Competitive Analysis, 2025 - 2033

出版日
ページ情報
英文 174 Pages
納期
即日から翌営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
迅速微生物検査市場 - 成長、将来展望、競合分析、2025年～2033年
出版日: 2025年02月14日
発行: Acute Market Reports
ページ情報: 英文 174 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の迅速微生物検査市場は、広範な診断薬産業の中で急速に成長している分野です。これらの検査は、感染性微生物の早期検出と同定において重要な役割を果たし、迅速かつ的を絞った治療介入を可能にします。この市場を牽引しているのは、感染症の流行の増加、より迅速で正確な診断結果に対するニーズ、食品の安全性に対する関心の高まりです。市場の成長は、技術の進歩、ポイントオブケア検査（POCT）の採用拡大、規制環境の支援、研究開発投資の拡大、医療費の増加など、いくつかの要因に起因しています。迅速微生物検査の市場規模は、2025年から2033年にかけて9.7%のCAGRで拡大し、2024年の53億2,000万米ドルから2033年には122億6,000万米ドルに達すると予測されています。

より迅速で正確な診断結果に対するニーズが、迅速微生物検査に対する需要を牽引しています。感染症の診断の遅れは、罹患率、死亡率、ヘルスケアコストの増加につながります。例えば、Clinical Infectious Diseases誌に掲載された研究では、敗血症の診断が1日遅れると死亡率が7.6%増加すると推定されています。迅速微生物検査は、従来の方法に比べて大幅な時間短縮が可能です。例えば、PCR（ポリメラーゼ連鎖反応）のような分子検査では数時間で結果が得られるため、早期発見とタイムリーな治療決定が可能になります。迅速な診断は、入院期間の短縮、不必要な治療、広域抗生物質の使用削減によるコスト削減につながります。Journal of Clinical Microbiology誌に掲載された研究によると、血流感染に対する迅速分子診断法を導入することで、抗生物質の使用を最適化することができ、患者一人当たり2,016ドルのコスト削減につながっています。従来の培養ベースの方法は時間がかかり、決定的な結果が出るまでに数日を要します。対照的に、迅速微生物検査は、分子診断や免疫測定などの先端技術を活用し、微生物を迅速に検出・同定します。

迅速微生物検査は主に臨床現場で利用されてきました。しかし、環境モニタリング、食品安全検査、医薬品製造、動物用診断など、非臨床環境での用途を拡大する大きな機会があります。これらの分野では、迅速微生物検査が提供する迅速性、正確性、利便性から恩恵を受けることができ、新たな市場機会がもたらされます。

当レポートでは、世界の迅速微生物検査市場について調査し、市場の概要とともに、技術別、手法別、エンドユーザー別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 序文

第2章 エグゼクティブサマリー

第3章 迅速微生物検査市場：競合分析

  • 主要ベンダーの市場ポジショニング
  • ベンダーが採用する戦略
  • 主要業界戦略

第4章 迅速微生物検査市場：マクロ分析と市場力学

  • イントロダクション
  • 世界の迅速微生物検査の市場価値、2023年～2033年
  • 市場力学
  • 促進要因と抑制要因の影響分析
  • シーソー分析
  • ポーターのファイブフォースモデル
  • PESTEL分析

第5章 迅速微生物検査市場：技術別、2023年～2033年

  • 市場概要
  • 成長と収益分析：2024年対2033年
  • 市場セグメンテーション
    • 核酸ベースの検査
    • 抗体ベースの検査
    • 生化学検査
    • 酵素テスト
    • フローサイトメトリー法
    • ポリメラーゼ連鎖反応（PCR）法
    • インピーダンス法
    • その他

第6章 迅速微生物検査市場：手法別、2023年～2033年

  • 市場概要
  • 成長と収益分析：2024年対2033年
  • 市場セグメンテーション
    • 増殖
    • 核酸
    • 生存能力

第7章 迅速微生物検査市場：エンドユーザー別、2023年～2033年

  • 市場概要
  • 成長と収益分析：2024年対2033年
  • 市場セグメンテーション
    • 食品・飲料
    • 製薬
    • 環境
    • パーソナルケア
    • その他

第8章 北米の迅速微生物検査市場：2023年～2033年

第9章 英国およびEUの迅速微生物検査市場：2023年～2033年

第10章 アジア太平洋の迅速微生物検査市場：2023年～2033年

第11章 ラテンアメリカの迅速微生物検査市場：2023年～2033年

第12章 中東・アフリカの迅速微生物検査市場：2023年～2033年

第13章 企業プロファイル

  • Abbott Laboratories Inc.
  • Danaher Corporation
  • Becton Dickinson And Company
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Bruker Corporation
  • BioMerieux
  • Bio-Rad Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Neogen Corporation
  • Siemens Healthineers AG
  • Charles River Laboratories International Inc.
  • QIAGEN NV
  • 3M Company
  • DiaSorin
図表

List of Tables

  • TABLE 1 Global Rapid Microbiology Tests Market By Technology, 2023-2033, USD (Million)
  • TABLE 2 Global Rapid Microbiology Tests Market By Method, 2023-2033, USD (Million)
  • TABLE 3 Global Rapid Microbiology Tests Market By End User, 2023-2033, USD (Million)
  • TABLE 4 North America Rapid Microbiology Tests Market By Technology, 2023-2033, USD (Million)
  • TABLE 5 North America Rapid Microbiology Tests Market By Method, 2023-2033, USD (Million)
  • TABLE 6 North America Rapid Microbiology Tests Market By End User, 2023-2033, USD (Million)
  • TABLE 7 U.S. Rapid Microbiology Tests Market By Technology, 2023-2033, USD (Million)
  • TABLE 8 U.S. Rapid Microbiology Tests Market By Method, 2023-2033, USD (Million)
  • TABLE 9 U.S. Rapid Microbiology Tests Market By End User, 2023-2033, USD (Million)
  • TABLE 10 Canada Rapid Microbiology Tests Market By Technology, 2023-2033, USD (Million)
  • TABLE 11 Canada Rapid Microbiology Tests Market By Method, 2023-2033, USD (Million)
  • TABLE 12 Canada Rapid Microbiology Tests Market By End User, 2023-2033, USD (Million)
  • TABLE 13 Rest of North America Rapid Microbiology Tests Market By Technology, 2023-2033, USD (Million)
  • TABLE 14 Rest of North America Rapid Microbiology Tests Market By Method, 2023-2033, USD (Million)
  • TABLE 15 Rest of North America Rapid Microbiology Tests Market By End User, 2023-2033, USD (Million)
  • TABLE 16 UK and European Union Rapid Microbiology Tests Market By Technology, 2023-2033, USD (Million)
  • TABLE 17 UK and European Union Rapid Microbiology Tests Market By Method, 2023-2033, USD (Million)
  • TABLE 18 UK and European Union Rapid Microbiology Tests Market By End User, 2023-2033, USD (Million)
  • TABLE 19 UK Rapid Microbiology Tests Market By Technology, 2023-2033, USD (Million)
  • TABLE 20 UK Rapid Microbiology Tests Market By Method, 2023-2033, USD (Million)
  • TABLE 21 UK Rapid Microbiology Tests Market By End User, 2023-2033, USD (Million)
  • TABLE 22 Germany Rapid Microbiology Tests Market By Technology, 2023-2033, USD (Million)
  • TABLE 23 Germany Rapid Microbiology Tests Market By Method, 2023-2033, USD (Million)
  • TABLE 24 Germany Rapid Microbiology Tests Market By End User, 2023-2033, USD (Million)
  • TABLE 25 Spain Rapid Microbiology Tests Market By Technology, 2023-2033, USD (Million)
  • TABLE 26 Spain Rapid Microbiology Tests Market By Method, 2023-2033, USD (Million)
  • TABLE 27 Spain Rapid Microbiology Tests Market By End User, 2023-2033, USD (Million)
  • TABLE 28 Italy Rapid Microbiology Tests Market By Technology, 2023-2033, USD (Million)
  • TABLE 29 Italy Rapid Microbiology Tests Market By Method, 2023-2033, USD (Million)
  • TABLE 30 Italy Rapid Microbiology Tests Market By End User, 2023-2033, USD (Million)
  • TABLE 31 France Rapid Microbiology Tests Market By Technology, 2023-2033, USD (Million)
  • TABLE 32 France Rapid Microbiology Tests Market By Method, 2023-2033, USD (Million)
  • TABLE 33 France Rapid Microbiology Tests Market By End User, 2023-2033, USD (Million)
  • TABLE 34 Rest of Europe Rapid Microbiology Tests Market By Technology, 2023-2033, USD (Million)
  • TABLE 35 Rest of Europe Rapid Microbiology Tests Market By Method, 2023-2033, USD (Million)
  • TABLE 36 Rest of Europe Rapid Microbiology Tests Market By End User, 2023-2033, USD (Million)
  • TABLE 37 Asia Rapid Microbiology Tests Market By Technology, 2023-2033, USD (Million)
  • TABLE 38 Asia Rapid Microbiology Tests Market By Method, 2023-2033, USD (Million)
  • TABLE 39 Asia Rapid Microbiology Tests Market By End User, 2023-2033, USD (Million)
  • TABLE 40 China Rapid Microbiology Tests Market By Technology, 2023-2033, USD (Million)
  • TABLE 41 China Rapid Microbiology Tests Market By Method, 2023-2033, USD (Million)
  • TABLE 42 China Rapid Microbiology Tests Market By End User, 2023-2033, USD (Million)
  • TABLE 43 Japan Rapid Microbiology Tests Market By Technology, 2023-2033, USD (Million)
  • TABLE 44 Japan Rapid Microbiology Tests Market By Method, 2023-2033, USD (Million)
  • TABLE 45 Japan Rapid Microbiology Tests Market By End User, 2023-2033, USD (Million)
  • TABLE 46 India Rapid Microbiology Tests Market By Technology, 2023-2033, USD (Million)
  • TABLE 47 India Rapid Microbiology Tests Market By Method, 2023-2033, USD (Million)
  • TABLE 48 India Rapid Microbiology Tests Market By End User, 2023-2033, USD (Million)
  • TABLE 49 Australia Rapid Microbiology Tests Market By Technology, 2023-2033, USD (Million)
  • TABLE 50 Australia Rapid Microbiology Tests Market By Method, 2023-2033, USD (Million)
  • TABLE 51 Australia Rapid Microbiology Tests Market By End User, 2023-2033, USD (Million)
  • TABLE 52 South Korea Rapid Microbiology Tests Market By Technology, 2023-2033, USD (Million)
  • TABLE 53 South Korea Rapid Microbiology Tests Market By Method, 2023-2033, USD (Million)
  • TABLE 54 South Korea Rapid Microbiology Tests Market By End User, 2023-2033, USD (Million)
  • TABLE 55 Latin America Rapid Microbiology Tests Market By Technology, 2023-2033, USD (Million)
  • TABLE 56 Latin America Rapid Microbiology Tests Market By Method, 2023-2033, USD (Million)
  • TABLE 57 Latin America Rapid Microbiology Tests Market By End User, 2023-2033, USD (Million)
  • TABLE 58 Brazil Rapid Microbiology Tests Market By Technology, 2023-2033, USD (Million)
  • TABLE 59 Brazil Rapid Microbiology Tests Market By Method, 2023-2033, USD (Million)
  • TABLE 60 Brazil Rapid Microbiology Tests Market By End User, 2023-2033, USD (Million)
  • TABLE 61 Mexico Rapid Microbiology Tests Market By Technology, 2023-2033, USD (Million)
  • TABLE 62 Mexico Rapid Microbiology Tests Market By Method, 2023-2033, USD (Million)
  • TABLE 63 Mexico Rapid Microbiology Tests Market By End User, 2023-2033, USD (Million)
  • TABLE 64 Rest of Latin America Rapid Microbiology Tests Market By Technology, 2023-2033, USD (Million)
  • TABLE 65 Rest of Latin America Rapid Microbiology Tests Market By Method, 2023-2033, USD (Million)
  • TABLE 66 Rest of Latin America Rapid Microbiology Tests Market By End User, 2023-2033, USD (Million)
  • TABLE 67 Middle East and Africa Rapid Microbiology Tests Market By Technology, 2023-2033, USD (Million)
  • TABLE 68 Middle East and Africa Rapid Microbiology Tests Market By Method, 2023-2033, USD (Million)
  • TABLE 69 Middle East and Africa Rapid Microbiology Tests Market By End User, 2023-2033, USD (Million)
  • TABLE 70 GCC Rapid Microbiology Tests Market By Technology, 2023-2033, USD (Million)
  • TABLE 71 GCC Rapid Microbiology Tests Market By Method, 2023-2033, USD (Million)
  • TABLE 72 GCC Rapid Microbiology Tests Market By End User, 2023-2033, USD (Million)
  • TABLE 73 Africa Rapid Microbiology Tests Market By Technology, 2023-2033, USD (Million)
  • TABLE 74 Africa Rapid Microbiology Tests Market By Method, 2023-2033, USD (Million)
  • TABLE 75 Africa Rapid Microbiology Tests Market By End User, 2023-2033, USD (Million)
  • TABLE 76 Rest of Middle East and Africa Rapid Microbiology Tests Market By Technology, 2023-2033, USD (Million)
  • TABLE 77 Rest of Middle East and Africa Rapid Microbiology Tests Market By Method, 2023-2033, USD (Million)
  • TABLE 78 Rest of Middle East and Africa Rapid Microbiology Tests Market By End User, 2023-2033, USD (Million)

List of Figures

  • FIG. 1 Global Rapid Microbiology Tests Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Rapid Microbiology Tests Market: Quality Assurance
  • FIG. 5 Global Rapid Microbiology Tests Market, By Technology, 2024
  • FIG. 6 Global Rapid Microbiology Tests Market, By Method, 2024
  • FIG. 7 Global Rapid Microbiology Tests Market, By End User, 2024
  • FIG. 8 Global Rapid Microbiology Tests Market, By Geography, 2024
  • FIG. 9 Market Geographical Opportunity Matrix - Global Rapid Microbiology Tests Market, 2024
  • FIG. 10Market Positioning of Key Rapid Microbiology Tests Market Players, 2024
  • FIG. 11 Global Rapid Microbiology Tests Market, By Technology, 2024 Vs 2033, %
  • FIG. 12 Global Rapid Microbiology Tests Market, By Method, 2024 Vs 2033, %
  • FIG. 13 Global Rapid Microbiology Tests Market, By End User, 2024 Vs 2033, %
目次
Product Code: 136949-02-25

The global rapid microbiology tests market is a rapidly growing sector within the broader diagnostics industry. These tests play a crucial role in the early detection and identification of infectious microorganisms, enabling prompt and targeted treatment interventions. The market is driven by the increasing prevalence of infectious diseases, the need for faster and more accurate diagnostic results, and the growing focus on food safety. The market growth can be attributed to several factors, including technological advancements, increasing adoption of point-of-care testing (POCT), supportive regulatory environments, growing investments in research and development, and increasing healthcare expenditure. The rapid microbiology tests market is expected to increase at a CAGR of 9.7% from 2025 to 2033, from US$ 5.32 billion in 2024 to US$ 12.26 billion by 2033.

Need for faster and more accurate diagnostic results

The need for faster and more accurate diagnostic results is driving the demand for rapid microbiology tests. Delayed diagnosis of infectious diseases can lead to increased morbidity, mortality, and healthcare costs. For instance, a study published in the Clinical Infectious Diseases journal estimated that a one-day delay in diagnosing sepsis resulted in a 7.6% increase in mortality. Rapid microbiology tests offer significant time savings compared to traditional methods. For example, molecular tests like PCR (polymerase chain reaction) can provide results in a matter of hours, enabling early detection and timely treatment decisions. Rapid diagnostics can lead to cost savings by reducing hospital stays, unnecessary treatments, and the use of broad-spectrum antibiotics. A study published in the Journal of Clinical Microbiology found that implementing rapid molecular diagnostics for bloodstream infections resulted in cost savings of $2,016 per patient by optimizing antibiotic use. Traditional culture-based methods can be time-consuming, requiring several days to yield conclusive results. In contrast, rapid microbiology tests leverage advanced technologies such as molecular diagnostics and immunoassays to detect and identify microorganisms swiftly.

Expansion of applications in non-clinical settings

Rapid microbiology tests have primarily been utilized in clinical settings. However, there is a significant opportunity to expand their applications in non-clinical settings, such as environmental monitoring, food safety testing, pharmaceutical manufacturing, and veterinary diagnostics. These sectors can benefit from the speed, accuracy, and convenience offered by rapid microbiology tests, presenting new market opportunities.

Limited adoption in resource-constrained settings

One significant restraint for rapid microbiology tests is their limited adoption in resource-constrained settings, particularly in low-income countries and regions with inadequate healthcare infrastructure. The cost of implementing these tests, the requirement for trained personnel, and the need for supporting laboratory facilities can pose challenges in resource-limited settings, hindering widespread adoption and accessibility. According to the World Health Organization (WHO), approximately one-third of healthcare facilities in low-income countries do not have access to basic diagnostic services. The lack of laboratory facilities, trained personnel, and funding in resource-constrained settings can hinder the implementation of rapid microbiology tests. A study published in the Journal of Global Antimicrobial Resistance found that the cost of implementing rapid diagnostics can be a major barrier in low-resource settings, where limited healthcare budgets may not accommodate the higher upfront costs.

Market Segmentation by Technology

The nucleic acid based test led the revenues in 2024 in the rapid microbiology tests market due to several reasons. Firstly, nucleic acid-based tests offer high sensitivity and specificity in detecting microorganisms. They utilize molecular techniques such as polymerase chain reaction (PCR) to amplify and detect specific nucleic acid sequences of pathogens. This allows for accurate and reliable identification of microorganisms, even at low concentrations, leading to increased adoption in various industries and healthcare settings. Secondly, nucleic acid-based tests have a wide range of applications in infectious disease diagnosis, environmental monitoring, and food safety. They can detect a diverse array of pathogens, including bacteria, viruses, fungi, and parasites, making them versatile and suitable for different testing requirements. This broad applicability has contributed to their widespread use and revenue generation.

Market Segmentation by End User

The Food & Beverage segment led the revenues in 2024 in the rapid microbiology tests market for several reasons. Firstly, the food and beverage industry is highly regulated and places a strong emphasis on ensuring product safety and quality. Microbiological contamination in food and beverages can lead to foodborne illnesses, product recalls, and damage to brand reputation. Therefore, rigorous microbiological testing is essential to identify and control potential microbial hazards. Secondly, there has been an increasing focus on food safety and quality globally, leading to a higher demand for rapid microbiology tests in the food and beverage industry. Consumers are becoming more conscious of the safety and origin of the food they consume, which has put pressure on manufacturers to implement robust testing protocols. Rapid microbiology tests enable timely detection and monitoring of microbial contamination, allowing companies to take corrective actions promptly and prevent the distribution of contaminated products.

Market Segmentation by Region

APAC (Asia-Pacific) is expected to register the highest compound annual growth rate (CAGR) during the forecast period of 2023 to 2031 in the global rapid microbiology tests market. APAC has a large and rapidly growing population, which leads to an increased demand for healthcare services. The region is witnessing a rise in infectious diseases, foodborne illnesses, and healthcare-associated infections, which has created a need for rapid and accurate microbiology tests. The increasing awareness about the importance of early diagnosis and infection control measures has further fueled the demand for rapid microbiology tests in APAC. There is a growing focus on improving healthcare infrastructure and expanding laboratory facilities in APAC countries. Governments and healthcare organizations are investing in the development of healthcare systems and upgrading laboratory capabilities. This investment facilitates the adoption of advanced testing technologies, including rapid microbiology tests, to enhance disease surveillance, infection control, and patient management.

The leading players in this market are Abbott Laboratories, Inc., Danaher Corporation, Becton, Dickinson And Company, Thermo Fisher Scientific, Inc., Merck KGaA, Bruker Corporation, BioMerieux, Bio-Rad Laboratories, F. Hoffmann-La Roche Ltd., Neogen Corporation, Siemens Healthineers AG, Charles River Laboratories International, Inc., QIAGEN N.V., 3M Company, DiaSorin.

Historical & Forecast Period

This study report represents an analysis of each segment from 2023 to 2033 considering 2024 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2025 to 2033.

The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends & technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. The key data points that enable the estimation of Rapid Microbiology Tests market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users & consumption volume, price, and value.

Geographical revenues generated by countries considered in the report

Micro and macro environment factors that are currently influencing the Rapid Microbiology Tests market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.

  • Market Segmentation
  • Technology
    • Nucleic Acid Based Test
    • Antibody Based Test
    • Biochemical Test
    • Enzymatic Test
    • Flow Cytometry Methods
    • Polymerase Chain Reaction (PCR) Methods
    • Impedance Methods
    • Others
  • Method
    • Growth
    • Nucleic Acid
    • Viability
  • End User
    • Food and Beverages
    • Pharmaceutical
    • Environmental
    • Personal Care
    • Others
  • Region Segment (2023-2033; US$ Million)
  • North America
  • U.S.
  • Canada
  • Rest of North America
  • UK and European Union
  • UK
  • Germany
  • Spain
  • Italy
  • France
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East and Africa
  • GCC
  • Africa
  • Rest of Middle East and Africa

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of Rapid Microbiology Tests market?
  • What are the key investment pockets concerning product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2033.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Rapid Microbiology Tests market?
  • Which is the largest regional market for Rapid Microbiology Tests market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Rapid Microbiology Tests market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Rapid Microbiology Tests market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Rapid Microbiology Tests Market
  • 2.2. Global Rapid Microbiology Tests Market, By Technology, 2024 (US$ Million)
  • 2.3. Global Rapid Microbiology Tests Market, By Method, 2024 (US$ Million)
  • 2.4. Global Rapid Microbiology Tests Market, By End User, 2024 (US$ Million)
  • 2.5. Global Rapid Microbiology Tests Market, By Geography, 2024 (US$ Million)
  • 2.6. Attractive Investment Proposition by Geography, 2024

3. Rapid Microbiology Tests Market: Competitive Analysis

  • 3.1. Market Positioning of Key Rapid Microbiology Tests Market Vendors
  • 3.2. Strategies Adopted by Rapid Microbiology Tests Market Vendors
  • 3.3. Key Industry Strategies

4. Rapid Microbiology Tests Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Rapid Microbiology Tests Market Value, 2023 - 2033, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis
  • 4.6. Porter's Five Force Model
    • 4.6.1. Supplier Power
    • 4.6.2. Buyer Power
    • 4.6.3. Threat Of Substitutes
    • 4.6.4. Threat Of New Entrants
    • 4.6.5. Competitive Rivalry
  • 4.7. PESTEL Analysis
    • 4.7.1. Political Landscape
    • 4.7.2. Economic Landscape
    • 4.7.3. Technology Landscape
    • 4.7.4. Legal Landscape
    • 4.7.5. Social Landscape

5. Rapid Microbiology Tests Market: By Technology, 2023-2033, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2024 Versus 2033
  • 5.3. Market Segmentation
    • 5.3.1. Nucleic Acid Based Test
    • 5.3.2. Antibody Based Test
    • 5.3.3. Biochemical Test
    • 5.3.4. Enzymatic Test
    • 5.3.5. Flow Cytometry Methods
    • 5.3.6. Polymerase Chain Reaction (PCR) Methods
    • 5.3.7. Impedance Methods
    • 5.3.8. Others

6. Rapid Microbiology Tests Market: By Method, 2023-2033, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2024 Versus 2033
  • 6.3. Market Segmentation
    • 6.3.1. Growth
    • 6.3.2. Nucleic Acid
    • 6.3.3. Viability

7. Rapid Microbiology Tests Market: By End User, 2023-2033, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2024 Versus 2033
  • 7.3. Market Segmentation
    • 7.3.1. Food and Beverages
    • 7.3.2. Pharmaceutical
    • 7.3.3. Environmental
    • 7.3.4. Personal Care
    • 7.3.5. Others

8. North America Rapid Microbiology Tests Market, 2023-2033, USD (Million)

  • 8.1. Market Overview
  • 8.2. Rapid Microbiology Tests Market: By Technology, 2023-2033, USD (Million)
  • 8.3. Rapid Microbiology Tests Market: By Method, 2023-2033, USD (Million)
  • 8.4. Rapid Microbiology Tests Market: By End User, 2023-2033, USD (Million)
  • 8.5.Rapid Microbiology Tests Market: By Region, 2023-2033, USD (Million)
    • 8.5.1.North America
      • 8.5.1.1. U.S.
        • 8.5.1.1.1. Rapid Microbiology Tests Market: By Technology, 2023-2033, USD (Million)
        • 8.5.1.1.2. Rapid Microbiology Tests Market: By Method, 2023-2033, USD (Million)
        • 8.5.1.1.3. Rapid Microbiology Tests Market: By End User, 2023-2033, USD (Million)
      • 8.5.1.2. Canada
        • 8.5.1.2.1. Rapid Microbiology Tests Market: By Technology, 2023-2033, USD (Million)
        • 8.5.1.2.2. Rapid Microbiology Tests Market: By Method, 2023-2033, USD (Million)
        • 8.5.1.2.3. Rapid Microbiology Tests Market: By End User, 2023-2033, USD (Million)
      • 8.5.1.3. Rest of North America
        • 8.5.1.3.1. Rapid Microbiology Tests Market: By Technology, 2023-2033, USD (Million)
        • 8.5.1.3.2. Rapid Microbiology Tests Market: By Method, 2023-2033, USD (Million)
        • 8.5.1.3.3. Rapid Microbiology Tests Market: By End User, 2023-2033, USD (Million)

9. UK and European Union Rapid Microbiology Tests Market, 2023-2033, USD (Million)

  • 9.1. Market Overview
  • 9.2. Rapid Microbiology Tests Market: By Technology, 2023-2033, USD (Million)
  • 9.3. Rapid Microbiology Tests Market: By Method, 2023-2033, USD (Million)
  • 9.4. Rapid Microbiology Tests Market: By End User, 2023-2033, USD (Million)
  • 9.5.Rapid Microbiology Tests Market: By Region, 2023-2033, USD (Million)
    • 9.5.1.UK and European Union
      • 9.5.1.1. UK
        • 9.5.1.1.1. Rapid Microbiology Tests Market: By Technology, 2023-2033, USD (Million)
        • 9.5.1.1.2. Rapid Microbiology Tests Market: By Method, 2023-2033, USD (Million)
        • 9.5.1.1.3. Rapid Microbiology Tests Market: By End User, 2023-2033, USD (Million)
      • 9.5.1.2. Germany
        • 9.5.1.2.1. Rapid Microbiology Tests Market: By Technology, 2023-2033, USD (Million)
        • 9.5.1.2.2. Rapid Microbiology Tests Market: By Method, 2023-2033, USD (Million)
        • 9.5.1.2.3. Rapid Microbiology Tests Market: By End User, 2023-2033, USD (Million)
      • 9.5.1.3. Spain
        • 9.5.1.3.1. Rapid Microbiology Tests Market: By Technology, 2023-2033, USD (Million)
        • 9.5.1.3.2. Rapid Microbiology Tests Market: By Method, 2023-2033, USD (Million)
        • 9.5.1.3.3. Rapid Microbiology Tests Market: By End User, 2023-2033, USD (Million)
      • 9.5.1.4. Italy
        • 9.5.1.4.1. Rapid Microbiology Tests Market: By Technology, 2023-2033, USD (Million)
        • 9.5.1.4.2. Rapid Microbiology Tests Market: By Method, 2023-2033, USD (Million)
        • 9.5.1.4.3. Rapid Microbiology Tests Market: By End User, 2023-2033, USD (Million)
      • 9.5.1.5. France
        • 9.5.1.5.1. Rapid Microbiology Tests Market: By Technology, 2023-2033, USD (Million)
        • 9.5.1.5.2. Rapid Microbiology Tests Market: By Method, 2023-2033, USD (Million)
        • 9.5.1.5.3. Rapid Microbiology Tests Market: By End User, 2023-2033, USD (Million)
      • 9.5.1.6. Rest of Europe
        • 9.5.1.6.1. Rapid Microbiology Tests Market: By Technology, 2023-2033, USD (Million)
        • 9.5.1.6.2. Rapid Microbiology Tests Market: By Method, 2023-2033, USD (Million)
        • 9.5.1.6.3. Rapid Microbiology Tests Market: By End User, 2023-2033, USD (Million)

10. Asia Pacific Rapid Microbiology Tests Market, 2023-2033, USD (Million)

  • 10.1. Market Overview
  • 10.2. Rapid Microbiology Tests Market: By Technology, 2023-2033, USD (Million)
  • 10.3. Rapid Microbiology Tests Market: By Method, 2023-2033, USD (Million)
  • 10.4. Rapid Microbiology Tests Market: By End User, 2023-2033, USD (Million)
  • 10.5.Rapid Microbiology Tests Market: By Region, 2023-2033, USD (Million)
    • 10.5.1.Asia Pacific
      • 10.5.1.1. China
        • 10.5.1.1.1. Rapid Microbiology Tests Market: By Technology, 2023-2033, USD (Million)
        • 10.5.1.1.2. Rapid Microbiology Tests Market: By Method, 2023-2033, USD (Million)
        • 10.5.1.1.3. Rapid Microbiology Tests Market: By End User, 2023-2033, USD (Million)
      • 10.5.1.2. Japan
        • 10.5.1.2.1. Rapid Microbiology Tests Market: By Technology, 2023-2033, USD (Million)
        • 10.5.1.2.2. Rapid Microbiology Tests Market: By Method, 2023-2033, USD (Million)
        • 10.5.1.2.3. Rapid Microbiology Tests Market: By End User, 2023-2033, USD (Million)
      • 10.5.1.3. India
        • 10.5.1.3.1. Rapid Microbiology Tests Market: By Technology, 2023-2033, USD (Million)
        • 10.5.1.3.2. Rapid Microbiology Tests Market: By Method, 2023-2033, USD (Million)
        • 10.5.1.3.3. Rapid Microbiology Tests Market: By End User, 2023-2033, USD (Million)
      • 10.5.1.4. Australia
        • 10.5.1.4.1. Rapid Microbiology Tests Market: By Technology, 2023-2033, USD (Million)
        • 10.5.1.4.2. Rapid Microbiology Tests Market: By Method, 2023-2033, USD (Million)
        • 10.5.1.4.3. Rapid Microbiology Tests Market: By End User, 2023-2033, USD (Million)
      • 10.5.1.5. South Korea
        • 10.5.1.5.1. Rapid Microbiology Tests Market: By Technology, 2023-2033, USD (Million)
        • 10.5.1.5.2. Rapid Microbiology Tests Market: By Method, 2023-2033, USD (Million)
        • 10.5.1.5.3. Rapid Microbiology Tests Market: By End User, 2023-2033, USD (Million)
      • 10.5.1.6. Rest of Asia Pacific
        • 10.5.1.6.1. Rapid Microbiology Tests Market: By Technology, 2023-2033, USD (Million)
        • 10.5.1.6.2. Rapid Microbiology Tests Market: By Method, 2023-2033, USD (Million)
        • 10.5.1.6.3. Rapid Microbiology Tests Market: By End User, 2023-2033, USD (Million)

11. Latin America Rapid Microbiology Tests Market, 2023-2033, USD (Million)

  • 11.1. Market Overview
  • 11.2. Rapid Microbiology Tests Market: By Technology, 2023-2033, USD (Million)
  • 11.3. Rapid Microbiology Tests Market: By Method, 2023-2033, USD (Million)
  • 11.4. Rapid Microbiology Tests Market: By End User, 2023-2033, USD (Million)
  • 11.5.Rapid Microbiology Tests Market: By Region, 2023-2033, USD (Million)
    • 11.5.1.Latin America
      • 11.5.1.1. Brazil
        • 11.5.1.1.1. Rapid Microbiology Tests Market: By Technology, 2023-2033, USD (Million)
        • 11.5.1.1.2. Rapid Microbiology Tests Market: By Method, 2023-2033, USD (Million)
        • 11.5.1.1.3. Rapid Microbiology Tests Market: By End User, 2023-2033, USD (Million)
      • 11.5.1.2. Mexico
        • 11.5.1.2.1. Rapid Microbiology Tests Market: By Technology, 2023-2033, USD (Million)
        • 11.5.1.2.2. Rapid Microbiology Tests Market: By Method, 2023-2033, USD (Million)
        • 11.5.1.2.3. Rapid Microbiology Tests Market: By End User, 2023-2033, USD (Million)
      • 11.5.1.3. Rest of Latin America
        • 11.5.1.3.1. Rapid Microbiology Tests Market: By Technology, 2023-2033, USD (Million)
        • 11.5.1.3.2. Rapid Microbiology Tests Market: By Method, 2023-2033, USD (Million)
        • 11.5.1.3.3. Rapid Microbiology Tests Market: By End User, 2023-2033, USD (Million)

12. Middle East and Africa Rapid Microbiology Tests Market, 2023-2033, USD (Million)

  • 12.1. Market Overview
  • 12.2. Rapid Microbiology Tests Market: By Technology, 2023-2033, USD (Million)
  • 12.3. Rapid Microbiology Tests Market: By Method, 2023-2033, USD (Million)
  • 12.4. Rapid Microbiology Tests Market: By End User, 2023-2033, USD (Million)
  • 12.5.Rapid Microbiology Tests Market: By Region, 2023-2033, USD (Million)
    • 12.5.1.Middle East and Africa
      • 12.5.1.1. GCC
        • 12.5.1.1.1. Rapid Microbiology Tests Market: By Technology, 2023-2033, USD (Million)
        • 12.5.1.1.2. Rapid Microbiology Tests Market: By Method, 2023-2033, USD (Million)
        • 12.5.1.1.3. Rapid Microbiology Tests Market: By End User, 2023-2033, USD (Million)
      • 12.5.1.2. Africa
        • 12.5.1.2.1. Rapid Microbiology Tests Market: By Technology, 2023-2033, USD (Million)
        • 12.5.1.2.2. Rapid Microbiology Tests Market: By Method, 2023-2033, USD (Million)
        • 12.5.1.2.3. Rapid Microbiology Tests Market: By End User, 2023-2033, USD (Million)
      • 12.5.1.3. Rest of Middle East and Africa
        • 12.5.1.3.1. Rapid Microbiology Tests Market: By Technology, 2023-2033, USD (Million)
        • 12.5.1.3.2. Rapid Microbiology Tests Market: By Method, 2023-2033, USD (Million)
        • 12.5.1.3.3. Rapid Microbiology Tests Market: By End User, 2023-2033, USD (Million)

13. Company Profile

  • 13.1. Abbott Laboratories, Inc.
    • 13.1.1. Company Overview
    • 13.1.2. Financial Performance
    • 13.1.3. Product Portfolio
    • 13.1.4. Strategic Initiatives
  • 13.2. Danaher Corporation
    • 13.2.1. Company Overview
    • 13.2.2. Financial Performance
    • 13.2.3. Product Portfolio
    • 13.2.4. Strategic Initiatives
  • 13.3. Becton, Dickinson And Company
    • 13.3.1. Company Overview
    • 13.3.2. Financial Performance
    • 13.3.3. Product Portfolio
    • 13.3.4. Strategic Initiatives
  • 13.4. Thermo Fisher Scientific, Inc.
    • 13.4.1. Company Overview
    • 13.4.2. Financial Performance
    • 13.4.3. Product Portfolio
    • 13.4.4. Strategic Initiatives
  • 13.5. Merck KGaA
    • 13.5.1. Company Overview
    • 13.5.2. Financial Performance
    • 13.5.3. Product Portfolio
    • 13.5.4. Strategic Initiatives
  • 13.6. Bruker Corporation
    • 13.6.1. Company Overview
    • 13.6.2. Financial Performance
    • 13.6.3. Product Portfolio
    • 13.6.4. Strategic Initiatives
  • 13.7. BioMerieux
    • 13.7.1. Company Overview
    • 13.7.2. Financial Performance
    • 13.7.3. Product Portfolio
    • 13.7.4. Strategic Initiatives
  • 13.8. Bio-Rad Laboratories
    • 13.8.1. Company Overview
    • 13.8.2. Financial Performance
    • 13.8.3. Product Portfolio
    • 13.8.4. Strategic Initiatives
  • 13.9. F. Hoffmann-La Roche Ltd.
    • 13.9.1. Company Overview
    • 13.9.2. Financial Performance
    • 13.9.3. Product Portfolio
    • 13.9.4. Strategic Initiatives
  • 13.10. Neogen Corporation
    • 13.10.1. Company Overview
    • 13.10.2. Financial Performance
    • 13.10.3. Product Portfolio
    • 13.10.4. Strategic Initiatives
  • 13.11. Siemens Healthineers AG
    • 13.11.1. Company Overview
    • 13.11.2. Financial Performance
    • 13.11.3. Product Portfolio
    • 13.11.4. Strategic Initiatives
  • 13.12. Charles River Laboratories International, Inc.
    • 13.12.1. Company Overview
    • 13.12.2. Financial Performance
    • 13.12.3. Product Portfolio
    • 13.12.4. Strategic Initiatives
  • 13.13. QIAGEN N.V.
    • 13.13.1. Company Overview
    • 13.13.2. Financial Performance
    • 13.13.3. Product Portfolio
    • 13.13.4. Strategic Initiatives
  • 13.14. 3M Company
    • 13.14.1. Company Overview
    • 13.14.2. Financial Performance
    • 13.14.3. Product Portfolio
    • 13.14.4. Strategic Initiatives
  • 13.15. DiaSorin
    • 13.15.1. Company Overview
    • 13.15.2. Financial Performance
    • 13.15.3. Product Portfolio
    • 13.15.4. Strategic Initiatives